Tech Transfer Showcase Application Opening in May
|
Applications for the BioNTX University Tech Transfer Showcase opening soon!
The Tech Transfer Showcase at the iC³ Life Science Summit provides founders with an opportunity to present innovative intellectual property to a select audience of investors and industry leaders, opening doors to potential collaborations and funding opportunities. Become part of the growing legacy of North Texas Life Sciences and apply to present your company!
|
Strategies for Success in Securing Grants and Advancing R&D
|
Join BioNTX for an exclusive webinar as founders, grant experts, and industry consultants delve into the organizational intricacies of funding agencies and how to craft a funding pathway aligned with your stage of development. Explore strategies to progress from early, smaller nondilutive awards like SBIRs or NIH grants, to securing larger awards for advanced R&D endeavors. Don't miss this opportunity to learn how to effectively navigate the funding ecosystem and optimize your path to success!
|
Navigating Clinical Trials & Maximizing Innovation in Drug Therapy Development
|
Join BioNTX and Caidya for an engaging, in-depth exploration of the clinical trial landscape and the necessary steps to ensure successful outcomes.
Caidya's team of dedicated experts will discuss effective strategies to streamline early phase trial design and address CMC challenges head-on. Founders and innovators, come learn how to better optimize efficiency while fostering innovation in your pipelines.
|
After the program, relax and unwind with peers, founders, and innovators at our April BIO BREAK Happy Hour sponsored by Caidya. Come forge genuine connections for professional business growth, and experience the vibrant North Texas Life Science ecosystem.
|
Innovation Comes to Life in Little Elm
for an Evening with BioNTX Facilities Committee
|
(above, center): Members of the BioNTX Facilities Advisory Committee with leaders from the Little Elm EDC and Retractable Technologies at the Elm Hotel
|
Retractable Technologies (RTI), has been pioneering innovative medical device manufacturing in Little Elm, Texas for 30 years. In a significant milestone, the BioNTX Facilities Advisory Committee joined hands with the city of Little Elm to host an exclusive site tour of RTI's manufacturing facility.
Celebrating this remarkable 30-year legacy, the event not only showcased RTI's cutting-edge technology but also highlighted the vibrant future of our life science community. Following the tour, attendees were graciously hosted by the Little Elm Economic Development Corporation for an afternoon happy hour at the chic Elm Hotel.
|
These events are a testament to the enduring partnership between industry leaders, local authorities,
and our community; laying the foundation for continued collaboration and prosperity in North Texas.
|
BioWorks for North Texas Graduates Inaugural Biotechnology Workforce Training Cohort at Collin College
|
(above, center): Professor Carole Twichell, MS, with students at Collin College's Microbiology Lab
|
The BioWorks for North Texas proudly announced the graduation of 40 (forty) Collin College students with entry-level certifications in biotechnology. The group is the first cohort to emerge from a regional biotechnology and healthcare workforce training initiative that tapped four, college-university partners in North Texas to collaboratively develop program curricula in alignment with expressed industry needs. A second cohort of students are actively enrolled at Collin College, with several additional training pathways slated to launch in summer 2024 at partner institutions Dallas College, UT Arlington, and Tarrant County College.
The BioWorks for North Texas training comes at a crucial time as the region faces a demand for thousands of biotechnology, pharmaceutical manufacturing, and healthcare workers. BioNTX celebrates this landmark initiative, as it not only provides students with essential skills but also serves as a vital resource for the local community, bridging the gap between education and employment in the emerging fields of biotechnology and healthcare.
|
MassChallenge Welcomes Innovators and Founders to Pegasus Park for Cashflow & Revenue Masterclass
|
Founded in 2009 in Boston, Massachusetts, MassChallenge’s mission is to equip bold entrepreneurs to disrupt the status quo and create meaningful change. The accelerator organization hosted med tech innovators and startup entrepreneurs for an Impact Lunch & Learn event this week at Pegasus Park during which attendees received invaluable mentorship and actionable insights on strategic decision-making, operational efficiency, and scaling business.
|
The MassChallenge Impact Lunch & Learn series adds to the growing support infrastructure for startups and innovators in North Texas, offering a dose of inspiration and industry wisdom at Pegasus Park.
|
(above): Lunch & Learn attendees at Health Wildcatters HQ in Pegasus Park
|
Northwestern Kellogg School of Business Hosts National Leaders
for Future of Healthcare Innovation Summit
|
The Northwestern Kellogg Business School hosted The Future of Healthcare Summit with their DFW Alumni Network at Pegasus Park. The day featured amazing panel discussions, networking breaks,
BioNTX joined diverse leaders to discuss economic strategies, how to drive impact, and the intersection of tech, science and equity aimed towards healthcare innovation.
|
(above): Panelists engaging with audience members
|
Eliminating Health Disparities with More Good Days
|
Join Good Days for an amazing opportunity to learn from health equity experts about critically important issues affecting millions of Americans every day. Patient advocacy leaders will discuss current problems in access to care for diverse communities across the U.S.
Register to hear from members of Congress, leaders of national patient advocacy groups, and academics on current initiatives that address health and access to care issues for diverse racial and ethnic populations throughout the United States.
|
Tranexamic Technologies Joins
Johnson & Johnson Innovation, JLABS
|
Tranexamic Technologies has announced their acceptance into the Johnson & Johnson Innovation JLABS program. This milestone partnership signifies a significant leap forward in the company's mission to drive healthcare innovation worldwide. As a resident company of JLABS, Tranexamic Technologies is poised to leverage the extensive resources and collaborative opportunities offered by this premier life science incubator network.
|
How Advanced Blood Testing is Revolutionizing Care
for Lupus Patients
|
AMPEL BioSolutions introduces LuGENE®, a pioneering blood test powered by predictive artificial intelligence, poised to redefine the management of systemic lupus erythematosus (SLE). With its innovative approach, LuGENE® detects genetic biomarkers indicative of SLE flares, providing clinicians with invaluable insights for personalized treatment strategies tailored to individual patients. This breakthrough has the potential to significantly improve patient outcomes by enabling proactive management of SLE flare-ups.
|
Island Pharmaceuticals Blasts Through Phase 2 Trial
with Sights Set on Global Dengue Market at ASIA BIO
|
Island Pharmaceuticals' recent evaluation of its ISLA-101 drug candidate, based on a single ascending dose study involving 24 subjects, has revealed highly promising pharmacokinetic data, providing crucial insights into its interaction within the human body. The assessment serves as a cornerstone for establishing precise dosing regimens for the upcoming Phase 2a clinical trial, marking a significant step forward in addressing the global health challenge of dengue fever.
|
Leveraging AI for Optimized Vector Designs with Form Bio
|
Form Bio has quickly positioned itself as a leader in Artificial Intelligence and Large Language Models. The company's AI models accurately predict and optimize vector design outcomes, as demonstrated through reproducible predictions across 42 constructs. With their latest report, Form Bio presents an analysis of the initial biological data and performance metrics of their FORMsightAI, explaining how AI-generated vector designs effectively address design problems, reduce the risk of immunotoxicity, and enhance yields.
Gain a deeper understanding of the AI's capability to increase desirable characteristics in vector designs, such as boosting genome titer and potency of mRNA and functional proteins. View the Form Bio validation report and learn about the transformative potential of Form Bio's AI-driven approach in revolutionizing vector design for biological applications.
|
ParaNano Wound Care Selected to Showcase Latest Innovations at Blue Knight Symposium
|
ParaNano Wound Care, a pioneering force in advanced wound care solutions, is set to take center stage at the upcoming Blue Knight Symposium, held in conjunction with BIO this June. The company's CEO, Chelsea Luxen has announced that ParaNano has been chosen as one of five highlighted mainstage companies for the Symposium showcase. The opportunity will allow ParaNano to pitch its groundbreaking technologies to a diverse audience of industry experts, investors, and stakeholders.
However, ParaNano's momentum doesn't stop there. The company recently captured the spotlight on multiple podcasts, shedding light on its remarkable journey and cutting-edge solutions. Notably, ParaNano was featured on a podcast hosted by the current Lt. Governor of Oklahoma, Matt Pinnell and highlighted on the MedTech Mini's podcast, a weekly series spotlighting emerging MedTech companies in 5 minutes or less.
Pushing the boundaries of scientific research, the company recently published a paper detailing its groundbreaking technology, based on research conducted at the University of Manitoba. This latest submission into the public record underscores ParaNano's commitment to advancing the field of wound care through cutting-edge research and development.
|
Good Days Announces 2024 Health Equity Campaign Calendar
|
Focused on patient assistance and advocacy, Good Days has announced their official calendar for the 2024 Chronic Disease Day campaign, slated for July 10th. The prominent non-profit's annual event aims to raise awareness about the impact of chronic illnesses, advocate for increased resources, and foster collaboration with partners in the Chronic Disease Alliance and health agencies at all levels. Led by President Clorinda Walley, Good Days remains committed to advancing initiatives for improved healthcare access, research, and support networks for those affected by chronic diseases.
|
Polsinelli Recognized for Excellence in Patent Law
|
Polsinelli is honored to be recognized in patent law rankings by the 2024 Intelligence Reports. The firm excels in both patent litigation and prosecution, ranking among the top 50 most active firms representing defendants in litigation and rapidly rising to the top 20 in the ITC Section 337 practice within its first year. Polsinelli also demonstrates notable growth and success in patent prosecution, showcasing its commitment to exceptional service and value for clients.
|
Baylor University Extends Award-winning Streak
as Top 100 Institution in Business, Law, and Utility Patents
|
Baylor University's graduate programs have already achieved remarkable success in the 2024 U.S. News rankings.
The announcement is the latest accolade awarded to the Baylor faithful following a trend of growth and innovation. The recognition places the university in rarified air; among MIT, Stanford, Harvard and Cal Tech; underscoring Baylor's commitment to excellence in graduate education across diverse fields.
|
Exploring the Human Element in Chronic Pain: UNT HSC Publishes PRECISION Study Findings in JAMA
|
The latest article in JAMA Network Open, titled "Physician Empathy and Chronic Pain Outcomes," explores data from the Pain Registry for Epidemiological, Clinical, and Interventional Studies and Innovation (PRECISION) at The University of North Texas Health Science Center at Fort Worth. Led by John C. Licciardone, DO, MS, MBA, Director of PRECISION, the study, conducted in collaboration with students from HSC’s Texas College of Osteopathic Medicine, including Yen Tran, Khang Ngo, David Toledo, and Navya Peddireddy, alongside Subhash Aryal, PhD, a registry biostatistician affiliated with Johns Hopkins University, examines 1,470 adults with chronic low-back pain. Their findings underscore a significant correlation between patient outcomes and physician empathy levels, emphasizing the pivotal role of empathy in chronic pain management.
|
John C. Licciardone, DO, MS, MBA
|
Igniting Innovation and Entrepreneurship for Economic Growth
|
UTA's Center for Entrepreneurship and Technology Development (CETD), led by Executive Director Paul Corson, is spearheading innovation and economic growth. CETD fosters entrepreneurship, technology commercialization, and company launches, benefiting local communities and the global economy. Through initiatives like workshops for the Arlington Latino Chamber of Commerce and the revitalization of UTA’s Student Entrepreneurship Club, CETD emphasizes UTA's dedication to entrepreneurship education and support.
|
Paul Corson, MA, Executive Director
|
UTD Energy Research Leads Offshore Wind Turbines
to Rethink Maintenance & Safety
|
(from left to right) Mechanical engineering professors Dr. Todd Griffith, Dr. Mario Rotea and Dr. Jie Zhang are working to develop remote-monitoring technology for offshore wind farms as part of a federal initiative funded through the Ocean Energy Safety Institute.
|
The Wind Energy Center at The University of Texas at Dallas is leading a project to improve safety for deep-water divers maintaining offshore wind turbines. With $500,000 in funding from a $2.7 million federal effort by the Ocean Energy Safety Institute, the project focuses on developing remote-monitoring technologies to mitigate risks faced by divers. By creating digital twins of wind turbines and analyzing simulation data, the project aims to detect equipment issues early, ensuring the safety and efficiency of offshore wind farm operations.
|
North Texas as a Beacon of Life Science & Tech Convergence
|
Kelly Cloud, VP of Life Sciences at the Dallas Regional Chamber, recently featured on the latest episode of the popular Innovate Fort Worth podcast detailing the vibrant biotech landscape, and sharing insights into past achievements and future aspirations for the region. Exploring the strategies that have propelled economic growth, Kelly echoes the Chamber's mandate to cultivate and attract talent within our thriving, local life sciences and biotechnology sectors. With the unprecedented growth taking place across North Texas, life science innovators and companies alike have taken notice that DFW is no longer an emerging market- rather, a verified industry hub.
|
UT Southwestern Announces Breakthrough Research
Advancing Our Understanding of Neurodegenerative Disease
|
(above): Distinct, self-propagating conformations of the tau protein produce unique morphologies. Researchers have since discovered that different strains trigger distinct, transmissible patterns of neurodegeneration.
|
UT Southwestern Medical Center researchers, led by Lukasz Joachimiak, Ph.D., have made a breakthrough in understanding neurodegenerative diseases. Their study in Structure reveals how oligomeric chaperones, especially DNAJB8, suppress misshaped protein formation linked to conditions like Alzheimer’s and Parkinson’s. This discovery, supported by UTSW’s Peter O’Donnell Jr. Brain Institute, offers potential for targeted diagnostic and therapeutic strategies against these diseases.
|
A Commitment to Advancing Science and Serving Researchers
Led GL CHEMTEC to Green Innovation
|
Since 2002, GL CHEMTEC has been a leading, independent CRO/CDMO partner providing innovative solutions and technologies to various industries, including pharmaceutical, biotech, medical device/biomedical materials, ophthalmology, and tailored polymers. The company's comprehensive services cover virtually all areas of the drug development process from discovery to manufacturing, utilizing state-of-the-art facilities.
Green chemistry is a core value that shapes the company's approaches, processes, and operations; forging enduring partnerships with top-tier life science establishments worldwide, constantly striving for excellence in areas such as small molecule R&D, process development, scale-up, green chemistry, and drug delivery.
|
FUNDING & MENTORSHIP OPPORTUNITIES
|
TechFW Brings North Texas into Space Alliance as State Looks to Innovate the Final Frontier
|
TechFW and the Bay Area Houston Economic Partnership have issued a call for startups and companies to engage with the Space Alliance Technology Outreach Program (SATOP).
The SATOP is a state-funded Texas program administered by the Bay Area Houston Economic Partnership that provides free technical assistance to small businesses, startups, and entrepreneurs located in Texas. SATOP offers technical assistance through two programs:
- The 40 Hour Technical Assistance Program
- The Texas A&M Capstone Design Program
A consortium of Space Alliance Partners is the driving force behind the Space Alliance Technology Outreach Program (SATOP). Aerospace companies, universities, colleges, and the NASA Johnson Space Center have committed to provide free labor hours to assist small business owners in solving technical challenges.
|
Startup Prize Focus on Health Competition
Means Opportunity for Innovators
Application closes on April 19, 2024
|
Startup Prize: Focus on Health is a national entrepreneurial competition for early stage health-focused startups. We connect entrepreneurs with mentors, resources and investors at zero cost and zero equity to the founder for a chance to battle test their concepts and walk away with $10,000 in non-dilutive funding and other potential investment.
|
The Hill Prizes
Recognizing Life Science Innovators & High-Impact Research
Applications open May 1, 2024
|
Generously funded by Lyda Hill Philanthropies, the Hill Prizes aim to accelerate groundbreaking research ideas with high potential for real-world impact. These prizes celebrate the achievements of top innovators and researchers in Texas, spanning six categories: Medicine, Public Health, Engineering, Biological Sciences, Physical Sciences, and Technology. Each recipient of the prize will be awarded $500,000 in funding to further their work and drive innovation.
|
Chiesi Rare Disease Golden Ticket Competition
Applications due June 30, 2024
|
The Chiesi Golden Ticket Competition awards startups and companies 2 (two) Golden Tickets to a US BioLabs site. Each Golden Ticket provides one year of fully paid individual bench space and membership at a fully equipped laboratory designed to accelerate early-stage startup working on research and development in the gene editing and/or relevant viral and non-viral delivery technologies, for treating rare hematology, immunology, ophthalmology, dermatology, inborn errors of metabolism or metabolic diseases.
|
Unlocking Biotech: For the Non-Scientist
|
What role do the FDA and NIH play in drug discovery?
|
Join Biotech Primer and BioNTX for the BioBasics 101 class, which explores the basic principles and scope of Life Sciences. This course is designed for the NonScientist and delves into genetic engineering, biomanufacturing, and applying the fundamental biology principles used everyday in our industry
|
Upcoming Events & Opportunities
|
Eliminating Health Disparities
Join Good Days to hear from members of Congress, leaders of national patient advocacy groups, and academic experts on current initiatives that address health and access to care issues for diverse racial and ethnic populations throughout the US.
April 25, 2024 | Online
|
American Exceptionalism,
Innovation & Entrepreneurship
Join MassChallenge to explore American exceptionalism, innovation, and entrepreneurship and the opportunities for Texas to grow into a global tech hub.
April 30, 2024 | Dallas, TX
|
The Science of Socializing
Join Azzur Group for an evening of networking, where you can enjoy complimentary food and beverages, engage in meaningful conversations, and build valuable connections with like-minded individuals in the Life Sciences community.
May 2, 2024 | Dallas, TX
|
Convergence AI Dallas
Join Dallas Regional Chamber to hear cutting-edge trends and innovations in artificial intelligence (AI) and its potential for revolutionizing business practices.
May 2, 2024 | Irving, TX
|
2024 Ignite Golden Ticket
Join Ignite Healthcare to hear women leading digital health and medical device startups to win The Golden Ticket to participate in their one-of-a-kind Accelerator Program.
May 2, 2024 | Dallas, TX
|
Health Wildcatters Info Session
Join Health Wildcatters to learn more about their Fall Accelerator Program and get your questions answered.
May 7, 2024 | Online
|
Nucleate Texas Activator Program
Join Nucleate Texas to hear students talk about their novel and innovative solutions to today’s most challenging issues in life sciences for a chance to win a Golden Ticket at Biolabs!
May 7, 2024 | Dallas, TX
|
BIO BREAK
Join McDermott, Deloitte, and BioNTX for cocktails at May's BIO BREAK. We're thrilled to announce Caidya as our May BIO BREAK sponsor! Relax, engage with the life science community, and cultivate genuine connections that open doors to professional growth.
May 9, 2024 | Dallas, TX
|
See You at the 2024 BIO International Convention in June!
|
Join BioNTX and BIO to be apart of the world's largest international event for biotechnology, representing the full ecosystem of innovation and industry with over 20,000 leaders and professionals from across the globe.
|
The iC³ Life Science Summit: 10 Years of Innovation
October 3, 2024 - October 4, 2024
|
This year's 10th annual BioNTX iC³ Life Science Summit will provide dynamic platform and a gorgeous setting for the North Texas bioscience community to share insightful discussion, cutting-edge research, and emerging technologies set to revolutionize the future of healthcare and biomedicine. With a new, international focus; the 2024 iC³ Life Science Summit is proud to welcome the global life science community to North Texas.
|
Renew Your Membership in 2024
Our members are the Foundation of our work and the driving force behind industry growth in North Texas. BioNTX provides members with opportunities to connect and collaborate to gain business insights, thought leadership, access vital resources, share innovations, and increase market visibility.
|
|
